What does CUSIP 05455M100 represent in this 13F holders report?

CUSIP 05455M100 is the security identifier for AVRO - AVROBIO INC - COM used to aggregate holder disclosures.

How many institutions held AVRO - AVROBIO INC - COM in Q1 2022?

76 institutional investors reported AVRO - AVROBIO INC - COM for Q1 2022. Use the holders table for investor-level position and value details.

AVROBIO INC - COM (AVRO)

CUSIP: 05455M100

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / COM
Total 13F shares: 29,345,980
Total 13F value: $38,771,352
Share change: -5,700,067
SEC-reported price per share: $1.32
Number of holders: 76
Value change: -$18,696,221
Number of buys: 31
Number of sells: 54

Security key

05455M100

Report period

Q1 2022

Institutions

Top holders

AVRO full security history Ownership snapshot Full 13F holder table Tectonic Therapeutic, Inc. SEC filings Tectonic Therapeutic, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AVRO - AVROBIO INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

JPMORGAN CHASE & CO

Disclosed value leader

JPMORGAN CHASE & CO

Comparable rows

0/15

Latest evidence

31 Dec 2021

13F Highest disclosed value: $17,465,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

JPMORGAN CHASE & CO has the largest disclosed position value at $17.46M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens JPMORGAN CHASE & CO's linked filing trail.

Disclosed position value Top 5

JPMORGAN CHASE & CO $17.46M

Atlas Venture Life Science Adviso... $17.4M

BlackRock Finance, Inc. $13.31M

FEDERATED HERMES, INC. $9.99M

GMT CAPITAL CORP $9.99M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
JPMORGAN CHASE & CO	13F Company 13F	— denominator unverified	$17,465,000 4,536,431 shares	—	31 Dec 2021
Atlas Venture Life Science Advisors, LLC	13F Company 13F	— denominator unverified	$17,405,000 4,520,863 shares	—	31 Dec 2021
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$13,306,000 3,456,088 shares	—	31 Dec 2021
FEDERATED HERMES, INC.	13F Company 13F	— denominator unverified	$9,993,000 2,595,453 shares	—	31 Dec 2021
GMT CAPITAL CORP	13F Company 13F	— denominator unverified	$9,990,000 2,594,914 shares	—	31 Dec 2021
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$6,464,000 1,679,107 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

29,345,980

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %